Uso de corticoides en dermatitis atópica: Artículo de revisión
Use of corticosteroids in atopic dermatitis: Review article
DOI:
https://doi.org/10.56712/latam.v5i5.2701Palabras clave:
dermatitis atópica, corticoides, eficiencia, uso prolongadoResumen
La dermatitis atópica (DA) es una enfermedad inflamatoria crónica de la piel que afecta principalmente a niños, caracterizada por picazón y enrojecimiento. Su tratamiento habitual son los corticoides tópicos, aunque su uso prolongado puede tener efectos secundarios. El objetivo principal es actualizar conocimientos sobre el uso de corticoides en dermatitis atópica. En septiembre del 2024 se realizó un artículo de revisión sobre manejo de DA en base a corticoesteroides, este está basado en estudios de los últimos 5 años encontrados en base de datos como PubMed, MEDLINE, EMBASE y Google Académico. Se identificaron 20 estudios que cumplen con los criterios de inclusión e incluyen definición, etiología, fisiopatología, manejo, tratamiento a base de corticoides, mecanismo de acción, eficiencia y efectos secundarios del tema descrito. La dermatitis atópica necesita un manejo multifacético, donde los corticoides tópicos son esenciales para aliviar síntomas y controlar brotes. La educación del paciente y la selección adecuada de tratamientos son cruciales para mejorar la calidad de vida. Integrar corticoides con otras terapias permite un enfoque personalizado y efectivo.
Descargas
Citas
Armario-Hita JC, Galán-Gutiérrez M, Dodero-Anillo JM, Carrascosa JM, Ruiz-Villaverde R. Updated review on treatment of atopic dermatitis. J Investig Allergol Clin Immunol [Internet]. 2023;33(3):158–67. Available from: https://www.jiaci.org/revistas/vol33issue3_1.pdf DOI: https://doi.org/10.18176/jiaci.0906
Drucker AM, Ellis AG, Bohdanowicz M, Mashayekhi S, Yiu ZZN, Rochwerg B, et al. Systemic immunomodulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis. JAMA Dermatol. 2020;156(6):659-667. DOI: https://doi.org/10.1001/jamadermatol.2020.0796
Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2019;80(1):85-94.
Frazier W, Bhardwaj N. Atopic Dermatitis: Diagnosis and Treatment. Am Fam Physician [Internet]. 2020;101(10):590–8. Available from: https://www.aafp.org/pubs/afp/issues/2020/0515/p590.html
He H, Del Duca E, Diaz A, Kim HJ, Aloia T, Aleshin M, et al. Mild topical corticosteroids reduce Staphylococcus aureus colonization in atopic dermatitis. J Allergy Clin Immunol Pract. 2020;8(10):3407-3416.e4.
Nedoszytko B, Reszka E, Gutowska-Owsiak D, Trzeciak M, Lange M, Jarczak J, et al. Genetic and epigenetic aspects of atopic dermatitis. Int J Mol Sci [Internet]. 2020;21(18):6484. Available from: https://www.mdpi.com/1422-0067/21/18/6484 DOI: https://doi.org/10.3390/ijms21186484
Paller AS, Eichenfield LF, Kirsner RS, et al. Topical corticosteroids in atopic dermatitis: A randomized, controlled, long-term safety study. J Am Acad Dermatol. 2020;82(2):365-374.
Paller AS, Siegfried EC, Eichenfield LF, Langley RG, Hultsch T, Simpson EL, et al. Safety and efficacy of crisaborole ointment, a nonsteroidal phosphodiesterase 4 inhibitor, in the treatment of mild-to-moderate atopic dermatitis: results from two pivotal phase 3 trials. J Am Acad Dermatol. 2016;75(3):494-503.e6.12.
Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2020;71(2):327-349. DOI: https://doi.org/10.1016/j.jaad.2014.03.030
Sidbury R, Gutman AB, Brunner PM, Vogelbaum M, Monahan C, Tsou A, et al. Pediatric atopic dermatitis: Management of mild to moderate disease in the primary care setting. Pediatrics. 2020;145(1)
Sidbury R, Kodama S, Yoshihara D, Joffe L, Kohen R. Evidence-based clinical recommendations for the use of topical corticosteroids in atopic dermatitis. Pediatr Dermatol. 2019;36(2):129-139.
Silverberg JI, Kantor R, Simpson EL. Current and emerging therapies for atopic dermatitis: A systematic review. JAMA Dermatol. 2020;156(2):246-255
Silverberg JI, Lei D, Yousaf M, et al. A systematic review of persistence of atopic dermatitis and eczema in population and patient cohorts. J Am Acad Dermatol. 2021;84(5):1276-1292.
Simpson EL, Gooderham M, Wollenberg A, Weidinger S, Armstrong A, Soung J, et al. Efficacy and safety of lebrikizumab in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis: A randomized clinical trial (ADhere). JAMA Dermatol [Internet]. 2023;159(2):182. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/2800236 DOI: https://doi.org/10.1001/jamadermatol.2022.5534
Sroka-Tomaszewska J, Trzeciak M. Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci [Internet]. 2021;22(8):4130. Available from: https://www.mdpi.com/1422-0067/22/8/4130 DOI: https://doi.org/10.3390/ijms22084130
Stacey SK, McEleney M. Topical Corticosteroids: Choice and Application. Am Fam Physician [Internet]. 2021;103(6):337–43. Available from: https://www.aafp.org/pubs/afp/issues/2021/0315/p337.html
Thyssen JP, Andersen YMF, Halling-Overgaard AS, et al. Treatment of atopic dermatitis with topical corticosteroids and the risk of osteoporosis and fractures. JAMA Dermatol. 2019;155(6):698-701.
Torres T, Ferreira EO, Gonçalo M, Mendes-Bastos P, Selores M, Filipe P. Update on Atopic Dermatitis. Acta Med Port [Internet]. 2019;32(9):606–13. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/11963 DOI: https://doi.org/10.20344/amp.11963
Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657-682. DOI: https://doi.org/10.1111/jdv.14891
Worm M, Francuzik W, Kraft M, et al. Evidence and consensus-based (S3) guidelines for the treatment of atopic dermatitis (atopic eczema)—update 2020. J Eur Acad Dermatol Venereol. 2020;34(8):1742-1769.
